Stay updated on ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial page.

Latest updates to the ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2 on the site.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedAdded revision note v3.5.0 and removed revision v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the revision history.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded Revision: v3.4.2 and removed the older notices (government funding lapse notice and Revision: v3.4.1). These are general site maintenance updates and do not affect the study data or how users view this page.SummaryDifference0.4%

- Check82 days agoChange DetectedA site-wide notice regarding government funding status was added and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check89 days agoChange DetectedAdded a glossary toggle and a new 'Last Update Submitted that Met QC Criteria' label; updated the site revision to v3.4.0 and standardized capitalization of 'No FEAR Act' data, with minor wording changes.SummaryDifference0.2%

Stay in the know with updates to ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial page.